In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide lost an average of 22.5 percent of their body weight at 72 weeks (Jastreboff et al., NEJM , 2022), compared to roughly 15 percent with semaglutide 2.4 mg in the STEP 1 trial (Wilding et al., NEJM , 2021)
Guides on tirzepatide diet planning and foods to avoid on tirzepatide can help structure meals that prioritize protein despite reduced overall appetite
How to get started with NAD+ and glutathione IV therapy
If you're experiencing ongoing leg coldness with numbness or walking pain, Doctronic can help you get evaluated quickly and start appropriate treatment
Start your intake Why Semaglutide Without Insurance Remains Accessible and Practical Insurance coverage for semaglutide (Ozempic, Wegovy) often requires prior authorization, documented type 2 diabetes, or body mass index thresholdsrestrictions that exclude many candidates who would benefit from GLP-1 therapy